13 completed, 5 unknown, 1 enrolling by invitation, 1 not yet recruiting. 22 Phase 2, 7 Phase 3, 2 Phase 1.
Follow Myalgia: new trials by email Literature Review of Myalgia trials Research Report on Myalgia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Jaw Muscle Pain Post Wisdom Molar Surgery Temporo-masseteric Nerve Block Injection, Oral Pain Medications only - Post Operative Pain, Impacted Third Molar Tooth | Phase 2 | Not yet recruiting | Rutgers, The State University of New Jersey | 80 | 2026-09-01 | 2026-06-18 |
| The Effectiveness of CBD and CBN in the Treatment of Facial Pain and Headache of Muscular Origin An aqueous solution containing CBD and CBN, The aqueous solution of placebo - Myalgia, Muscle Pain | Phase 2 / Phase 3 | Enrolling by invitation | Wroclaw Medical University | 42 | 2025-04-01 | 2026-03-06 |
| Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A Botulinum toxin type A, Isotonic saline 0,9% - Temporomandibular Disorders | Phase 2 | Recruiting | Karolinska Institutet | 100 | 2023-11-14 | 2026-08-05 |
| CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia (FibroCann) cannabidiol and tetrahydrocannabinol, Placebo - Fibromyalgia | Phase 2 / Phase 3 | Unknown | FG Brasil LTDA | 40 | 2022-04-15 | 2022-04-11 |
| Arnica and the Management of Pain in Acute Musculoskeletal Extremity Injuries Arnica, Placebo - Pain, Muscle, Pain, Acute | Phase 2 / Phase 3 | Unknown | Children's Hospitals and Clinics of Minnesota | 324 | 2021-07-15 | 2022-03-17 |
| Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN) Hesperidin, Placebo - Covid19, Anosmia | Phase 2 | Completed | Montreal Heart Institute | 216 | 2021-02-18 | 2022-04-08 |
| Masseter Myofascial Pain Relief Following an Intra-muscular Injection With Botulinum Toxin Type A. Botulinum toxin type A, saline solution - Myalgia, Myofascial Pain | Phase 2 | Unknown | Region Örebro County | 48 | 2020-07-01 | 2020-06-11 |
| Effects of ReWin(d) Supplementation on the Recovery of DOMS Induced by Acute Exercice Polyherbal supplement: ReWin(d) vs Placebo - Muscle Soreness, Delayed-onset Muscle Soreness | Phase 2 | Completed | Natural Origins | 40 | 2018-10-22 | 2019-05-23 |
| Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy Gabapentin 300mg - Invasive Breast Cancer, Chemotherapeutic Toxicity | Phase 2 / Phase 3 | Unknown | British Columbia Cancer Agency | 46 | 2018-07-02 | 2018-06-25 |
| The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders Platelet-Rich Plasma intramuscular injections, Placebo Comparator: 0,9% NaCl intramuscular injections - PRP, Temporomandibular Disorder | Phase 2 / Phase 3 | Completed | Medical University of Silesia | 58 | 2017-12-07 | 2019-01-04 |
| COMBOPROFEN for Treatment of Muscular Pain Associated With Delayed Onset Muscle Soreness (DOMS) Comboprofen, Placebo, Ibuprofen - Delayed Onset Muscle Soreness, DOMS | Phase 2 | Completed | Spherium Biomed | 74 | 2017-07-12 | 2018-01-23 |
| Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors Neuromuscular taping - Breast Neoplasms | Phase 1 / Phase 2 | Completed | University of Malaga | 156 | 2016-05-01 | 2017-03-31 |
| Phase II Study of AP0302 5% Versus a Vehicle Comparator S-Ibuprofen Topical Gel 5%, Vehicle Topical Gel - Pain, Delayed Onset Muscle Soreness | Phase 2 | Completed | Aponia Laboratories, Inc. | 147 | 2015-01-01 | 2019-02-25 |
| Belimumab in Idiopathic Inflammatory Myositis Belimumab, Placebo - Myositis | Phase 2 / Phase 3 | Completed | Northwell Health | 17 | 2015-01-01 | 2024-02-09 |
| Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain Cunermuspir, Placebo - Neuralgia, Myalgia | Phase 1 / Phase 2 | Completed | Mitosynergy LLC | 56 | 2014-01-28 | 2021-04-20 |
| Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors Vitamin D3 - Muscle Pain, Joint Pain | Phase 2 | Completed | HealthPartners Institute | 116 | 2012-03-01 | 2019-06-18 |
| Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder Nutraceutical supplements, Placebo - Chronic Fatigue Syndrome | Phase 2 | Withdrawn | Columbia University | 2012-03-01 | 2015-04-13 | |
| Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain Loratadine, placebo - Pegfilgrastim-induced Back and Leg Pain | Phase 2 | Unknown | University of Vermont | 55 | 2011-05-01 | 2013-01-24 |
| Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM) PPD10558, Atorvastatin, Placebo - Myalgia, Hypercholesterolemia | Phase 2 | Completed | Furiex Pharmaceuticals, Inc | 282 | 2011-03-01 | 2011-12-22 |
| Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms Coenzyme Q10, Placebo - Pain, Weakness | Phase 2 / Phase 3 | Completed | Catherine Buettner | 68 | 2009-12-01 | 2017-01-23 |
Showing 20 of 22. Sign in to see all of them.
Arthralgia (5) · Pain (5) · Fatigue (2) · Fibromyalgia (2) · Headache (2) · Motor Activity (2) · Muscle Weakness (2) · Temporomandibular Joint Disorders (2) · Abdominal Pain (1) · Acute Pain (1) · Agnosia (1) · Anosmia (1) · Asthenia (1) · Breast Neoplasms (1)
Muscular Diseases (22) · Musculoskeletal Diseases (22) · Musculoskeletal Pain (22) · Nervous System Diseases (22) · Neurologic Manifestations (22) · Neuromuscular Diseases (22) · Pathological Conditions, Signs and Symptoms (22) · Signs and Symptoms (22) · Pain (17) · Joint Diseases (7) · Pathologic Processes (4) · Behavior (3) · Neurobehavioral Manifestations (3) · Stomatognathic Diseases (3) · Craniomandibular Disorders (2)
Botulinum Toxins, Type A (2) · Arnicae flos extract (1) · Ascorbic Acid (1) · Atorvastatin (1) · Cannabidiol (1) · Cannabinol (1) · Cholecalciferol (1) · Dronabinol (1) · Gabapentin (1) · Hesperidin (1) · Ibuprofen (1) · Loratadine (1) · Magnesium (1) · Saline Solution (1) · belimumab (1)
Aponia Laboratories, Inc. (1) · British Columbia Cancer Agency (1) · Catherine Buettner (1) · Children's Hospitals and Clinics of Minnesota (1) · Columbia University (1) · FG Brasil LTDA (1) · Furiex Pharmaceuticals, Inc (1) · HealthPartners Institute (1) · IDEA AG (1) · Karolinska Institutet (1) · Medical University of Silesia (1) · Mitosynergy LLC (1) · Montreal Heart Institute (1) · National Institute of Nursing Research (NINR) (1) · Natural Origins (1)
United States (10) · Spain (3) · Canada (2) · Poland (2) · Germany (1) · Sweden (1)
Aleksandra Nitecka-Buchta, DMD (1) · Alfred E Slonim, MD (1) · Alice C. Shapiro, PhD RD (1) · Antonio I Cuesta-Vargas, PhD (1) · Catherine Buettner, MD, MPH (1) · Daniel Ovesson, DDS (1) · Egbert Seidel, MD (1) · Galina Marder, MD (1) · Inmaculada Conejo-Tirado (1) · Jocelyn Dupuis, MD (1) · Leorey N Saligan, C.R.N.P. (1) · Malin Ernberg (1) · Manu Madhok, MD, MPH (1) · Margarita Perez Ruiz, MD(Res) (1)
PMID 26868123, PMID 26894485, PMID 29890985, PMID 32848820, PMID 37326854
2016 (1), K23AR055664 (1)